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Consumer-focused Supply Chains: A Cross-case Comparison of 
Medicine Appeal and Acceptance in India, Uganda and Nigeria 
 
 
Abstract   
Medicine adherence levels remain frustratingly static at 50% or lower 
(Sabaté, 2003). We believe that supply chains can contribute improvements 
by making appealing and acceptable medicines available to consumers. 
We use Service-Dominant Logic (Vargo & Lusch, 2004; Vargo & Lusch, 2008) 
to investigate consumption – the “last yard” of the supply chain – and 
empirical research performed in India, Uganda and Nigeria to assess how 
different populations view the formulation and packaging of Oral 
Rehydration Salts. The results and analysis provide new and actionable 
insights into medicine appeal and acceptance in the developing world. 
 
Keywords: medicine acceptance, medicine appeal, product design, supply 
chain, service-dominant logic 
 
 
Main Subject Text 
 
The challenge 
Medicine adherence levels remain frustratingly static at around 50% in the 
developed world (Brown & Bussell, 2011) and are likely to be lower in the 
developing world (Sabaté, 2003; Marcus, 2013). The World Health 
Organisation (WHO) has endorsed the idea that increasing adherence “may 
have a far greater impact on the health of the population than any 
improvement in specific medical treatments” (Sabaté, 2003, p.xiii). 
 
The study of adherence improvement has historically focused on increasing 
motivation through behaviour change (Kreps et al., 2011). However, there is 
some awareness – though little research – that other factors are important, 
including medicine appeal (Davis, 2007) and acceptance (Murray et al., 
2009; Shapiro et al., 1986). Together, appeal and acceptance determine 
whether medicine is acquired and consumed, hence whether patients are 
adherent and so can derive value from it. Appeal and acceptance are 
particularly relevant where there is a higher degree of consumer choice 
regarding choice of treatment. 
 
The treatment of diarrhoea in under-fives in developing countries is a good 
example of this. Acute diarrhoea is the second largest cause of death in 
children worldwide, causing 1.2 million deaths globally each year (Black et 
al., 2010). In 2004, WHO recommended the use of zinc and low-osmolarity 
Oral Rehydration Salts (ORS) as the best treatment for uncomplicated 
diarrhoea (WHO/UNICEF, 2004). These two products together could rapidly 
and cost-effectively avert most deaths not prevented by vaccines (Fischer 
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Walker et al., 2011). However, only about 30% of children with diarrhoea in 
high-burden countries receive ORS, and fewer than 1% receive the optimum 
treatment of ORS combined with zinc (Santosham et al., 2010); a total of 
67% of children receive potentially harmful treatment such as antibiotics, 
anti-motility drugs, or home remedies. Analysis of national household 
survey data (2005-2011) for the 19 high-burden countries shows that the 
majority of treatment-seeking for diarrhoea occurs in the private sector 
(retail stores and pharmacies). Making more appealing products available in 
this sector presents an opportunity to significantly increase adherence. 
 
The key challenge presented here is the need to design, present and market 
ORS and zinc products that have optimum consumer appeal (price, good 
taste, correct volume, appealing packaging), to move consumption away 
from incorrect treatment. Whilst both ORS and zinc pack designs were 
tested in the study, in order to give depth of results this paper focuses on 
the ORS findings. 
 
Theoretical basis for the research 
This section first considers factors affecting the decisions to consume, 
recognising that all consumption is controlled by internal and external 
drivers. Adherence is then introduced. Service-Dominant Logic (SDL) is then 
presented as a means to position the factors affecting consumption. Finally, 
consumption is shown to be relevant to supply chain management by 
establishing it as the “last yard” of the supply chain. 
 
“A Social and Economic Theory of Consumption” (Ilmonen, 2011) includes a 
review of the meanings of consumption. The value potentially obtained 
from consumption is not just determined from the offering itself but also 
from the experiences of the consumer and the perceptions of others. These 
personal experiences and external perceptions may determine whether 
consumption takes place or not, and if it does take place then in what way 
and in which circumstances. This suggests that all forms of consumption can 
be thought of as being determined, or controlled, by various internal and 
external forces. 
 
Adherence (sometimes called compliance) is defined as “the extent to which 
the patient's medication-taking history corresponds to the prescribed drug 
regimen” (Urquhart, 1999). This regimen may be specified by a prescription, 
standard treatment guidelines (STG), the health professional’s instructions, 
or other official communication. However, consumption theory indicates 
that the regimen is just one of the external forces determining 
consumption. Adherence is therefore a form of controlled consumption, 
where the regimen imposes the external control of frequency and timing 
but where other determinants also contribute to the decision to consume. 
According to a recent EU study (Ascertaining Barriers for Compliance 
Project, 2012), adherence is divided into three phases: initiation, 
implementation (persistence of consumption during the term of the 
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prescription), and discontinuation. The initiation phase represents the first 
decision to consume, and is where the two consumption determinants of 
medicine appeal and acceptance are most relevant. This applies to adult 
patients, but also to primary caregivers in the case of paediatric diarrhoea.  
  
It is surprising therefore that a literature review performed as part of the EU 
study (Kardas et al., 2013) categorised no fewer than 771 individual factors 
affecting adherence, but only three of the 51 papers included in the review 
addressed initiation in any form (ibid., p.5). In fact, only a small amount of 
research has been performed on medicine appeal and acceptance in any of 
the three phases. Examples include Shapiro et al. (1986) considering 
acceptance of different tablet colours, Mennella et al. (2013) investigating 
drug taste, More & Srivastava (2010) looking at aesthetics of non-
prescription medicines and their packaging, and ElMasry & Kipkeu (2010) 
investigating options for Coartem® packaging. These found that the 
appearance of drug packaging can indeed affect the initiation phase of 
adherence. 
 
The thinking on adherence is well supported by the insights which Service-
Dominant Logic (Vargo & Lusch, 2008; Vargo & Lusch, 2004; Lusch & Vargo, 
2014) provides into consumer perceptions of value. According to SDL, 
consumption is better understood as co-creation of value in context by the 
consumer making use of the offering. The consumer exploits the 
affordances of the offering by exercising her agency within the constraints 
of her particular context (Figure 1). While agency, resources, contexts and 
constraints may differ even for different consumers in the same family, they 
will certainly not be the same across regions or countries. This implies that 
there is the potential for significant contextual variety (Ng & Briscoe, 2012) 
in any population that we consider, and it is therefore necessary to 
understand that when developing truly patient-centric products. 
 
Much adherence research has emphasised the need to “change the 
patient”, implicitly placing the blame for non-adherence on a lack of 
motivation. However, the lens of SDL permits the value proposition of the 
offering to be investigated. In this case, the option to “change the offering” 
may be appropriate in order to address varying contexts. This therefore 
recognises the need for medicine packaging and formulation to be 
perceived positively by patients in order to enhance its appeal and 
acceptance (Figure 1). 
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Figure 1: Adherence and "last yard" consumption using the lens of Service-
Dominant Logic 
 
Supply chain research (for example Bustinza, Parry, & Vendrell-Herrero, 
2013; Hilletofth, 2011; Jüttner, Christopher, & Godsell, 2010; Stank, Esper, 
Crook, & Autry, 2012) has begun to highlight the necessity to understand 
customer needs and then to make them known to supply chain partners. 
Generally, however, research and practice has focused on the creation and 
delivery of the product and not on its consumption. This means that 
knowledge of consumers’ use of the value proposition’s affordances in 
context has not generally been utilised to improve the product and 
therefore adherence. 
 
In an attempt to address this, recent work by one of us (Ward, 2014) has 
looked at how SDL can be used to “include the customer consumption and 
experience within the remit of supply chain management” (Ng et al., 2015) 
in order to improve value propositions they create. SDL “places the 
customer inside the system… [and] considers value co-creation in use as 
part of the provider’s responsibility” (ibid.). The chosen approach has been 
to consider consumption to be the “last yard” of the supply chain, using a 
metaphor familiar to supply chain researchers and practitioners through 
analogues such as “last mile” and “last 50 yards”. 
 
In summary, adherence starts with initiation, and this decision to consume 
can be strongly influenced by the medicine’s appeal and acceptance to the 
intended caregivers and consumers. Supply chain partners may not realise 
that they have the opportunity to influence adherence unless they 
recognise that adherence is not just about consumer motivation but also 
about product appeal and acceptance. The “last yard” metaphor helps 
supply chain partners to take the opportunities thus presented. With such 
insights, they can work to develop a deeper understanding of consumer 
value co-creation contexts so they can improve the designs of medicines 
and packaging for their intended consumers. 
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Figure 2: Examples of the three pack designs tested in the research, in design order, 
with an old pack from Nigeria for comparison on the left 
We therefore propose two hypotheses for this study: 
• H1: Medicine pack design affects appeal and acceptance 
• H2: Medicine formulation affects appeal and acceptance. 
 
Methodology 
The primary objective of this qualitative study was to explore optimal 
product presentations and product improvements for Oral Rehydration Salts 
(ORS), leading to higher caregiver adherence in India, Uganda and Nigeria. 
Desk research reviewed existing qualitative and quantitative studies on 
diarrhoea treatment behaviour, while interviews with key stakeholders 
including Non-Governmental Organisation (NGO) program leads, ORS 
manufacturers and regulatory organizations gave an overview of current 
products used to treat diarrhoea as well as perceived benefits and barriers 
to ORS usage. Following this review, concept development workshops 
generated ideas for product re-design and improvement. Fifty product 
designs were created. From these, three pack designs were chosen, plus 
seven new formulation concepts believed to represent best-fit options for 
addressing the five identified barriers: difficulty of preparation, difficulty of 
sourcing clean water, ensuring correct dosage, poor taste, and high product 
wastage. Figure 2 shows the three pack designs together with an ORS sachet 
currently on the market in Nigeria (pack designs were subtly altered for the 
three focus countries to align them with local ethnicities). 
  
  
 
The seven formulation concepts were: smaller powder sachet, effervescent 
tablets dissolvable in water, premixed liquid in a plastic bottle, premixed 
liquid in a Tetra Pak, premixed liquid in a soft plastic pouch, powder sachet 
with water purifier included, and powder sachet and zinc tablets packaged 
together in a “co-pack”. 
 
These pack designs and formulations were then tested against the opinions 
of caregivers and healthcare providers from communities across India, 
Uganda and Nigeria. Quota sampling was used to recruit caregivers with 
children under five who had experienced an episode of diarrhoea within 
three months prior to the interview. The study included non-users of ORS, 
lapsed users and regular users. Sampling points were purposively selected 
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from rural, resource-poor districts with higher reported levels of diarrhoea 
incidence. 
 
Interviewers took each caregiver through the formulation concepts and 
pack designs using a monadic sequential approach. Concepts and designs 
were first shown separately to evaluate their appeal, what in particular the 
respondents liked/disliked or would improve, their willingness to pay, and 
their purchase intent. Concepts and designs were then shown together to 
evaluate overall preference as well as their perceived ability to overcome 
the current challenges of the product on the market. Results from the 
interviews helped identify areas of focus for further discussion. Attributes 
that came out negatively or did not come out clearly were probed in more 
detail in smaller group settings. 
 
A similar quota-based approach was used for the survey for healthcare 
providers, and this also relied on purposive sampling. Semi-structured 
interviews were conducted with drug shop owners, rural medical 
practitioners and community health workers at each respondent’s location. 
Interviews included both open and closed questions to validate the 
caregivers’ responses. Through this process a total of 630 caregivers and 
119 providers were reached across the three focus countries. The 
breakdown is shown in Table 1. 
 
Table 1: Respondent numbers by country and district 
 
Country State Districts Caregivers 
interviewed 
Healthcare 
providers 
interviewed 
India Madhya Pradesh 2 60 42 
Uttar Pradesh 4 120 
Nigeria Lagos 3 90 42 
Rivers 3 90 
Kano 3 90 
Uganda East 3 90 35 
North 3 90 
 
 
Results and analysis 
The results of the surveys provide empirical evidence of both common and 
differing preferences across the three focus countries. They confirmed that 
common barriers to ORS adherence were indeed the five identified from 
stakeholder interviews. Differing purchase intent between countries was 
evident, although comparison of figures between countries may not be valid 
as caregivers may have different attitudes towards surveys. 
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Users, lapsed users and non-users showed no difference in response, and 
therefore the analysis is presented on total caregiver population. Results 
from healthcare providers were similar to those of caregivers. 
 
We report first on packaging design appeal for ORS. Table 2 shows results 
for the three options. Across all three countries, the three packs were 
significantly preferred over existing designs on the market, and all achieved 
high ratings. These results confirm hypothesis H1: Medicine pack design 
affects appeal and acceptance. 
 
In India, there was no statistical difference between the three package 
design preferences, with 86% of those questioned saying they would 
“definitely buy” each of the three designs. Comments indicated that designs 
should not look too expensive and should emphasise that the product will 
taste good. The respondents were highly price-sensitive. Current pack 
designs tend to be monochromatic and non-graphic, therefore all designs 
were considered attractive. 
 
In Nigeria, designs 2 and 3 were both statistically preferred over design 1, 
with design 2 having the highest percentage of those questioned saying they 
would “definitely buy”. Comments indicated that a modern and “trendy” 
design was important. All three of the designs were considered by 
respondents to be more appealing than the current pack, but they felt the 
packs could be improved further in order to “captivate” them. 
 
In Uganda, as in Nigeria, designs 2 and 3 were both statistically preferred 
over design 1, with design 2 having the highest percentage of those 
questioned saying they would “definitely buy”. Respondents indicated that 
design 3 looked as if the child was in danger by being swung by its mother, 
and that no medicine could work as quickly as the respondents inferred 
from the picture. In contrast, the child on design 2 looked healthy and 
happy, and in addition the words on the package were clear. Respondents 
also felt that the blue text on white background looked most “medical”. 
 
Table 2: Average appeal scores out of 5 plus “definitely buy” purchase 
preference for the 3 package designs by country. Asterisked numbers for 
designs 2 and 3 are statistically significantly different (p<0.05) from design 1 
 
Country Pack 
design 1 
Pack 
design 2 
Pack 
design 3 
Purchase 
preference 
India 4.85 4.85 4.90 N/A (all 86%) 
Nigeria 4.49 4.65* 4.77* Design 2 (78%) 
Uganda 4.72 4.91* 4.91* Design 2 (91%) 
 
We now turn to ORS formulations. The respondents’ assessments of the 
seven options are in Table 3. The smaller sachet was popular in all three 
countries. Respondent comments indicated that this was due to it reducing 
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wastage and therefore being more economical. A consistent message from 
the interviews was dislike of the taste of the ORS. This may confirm bitter 
taste research (Mennella et al., 2013; Campbell et al., 2012) that has 
indicated a wide range of sensitivity in ethnically different populations on 
the African continent. Additional concerns about the taste of ORS 
incorporating water purifier were also common in all countries. Also 
consistent were issues with potential spillage of the premix in the soft 
plastic pouch. These results confirm hypothesis H2: Medicine formulation 
affects appeal and acceptance. 
 
Table 3: Average appeal scores out of 9 plus purchase preference for the 7 
formulations by country. Asterisked numbers are statistically significantly 
different (p<0.05) from the smaller sachet 
 
C’ntry Smaller 
sachet 
Efferv. 
tablet 
Premix 
Tetra 
Pak 
Premix 
bottle 
Premix 
pouch 
+Water 
purifier 
Co-pack 
with Zn 
Purchase 
preference 
India 8.32 8.28 8.25 8.02* 7.64* 8.35 7.36* Tetra Pak 
(43%) 
Nigeria 7.39 7.67 7.52 6.76* 6.99 6.95* 7.01 smaller 
sachet/ 
Tetra Pak 
(27%) 
Uganda 8.50 8.22* 8.48 7.89* 7.60* 8.25 8.45 Tetra Pak/ 
co-pack 
with Zn 
(15%) 
 
 
Considering country-specific results, in India there was no statistically 
significant difference between the appeals of a smaller powder sachet, an 
effervescent tablet, a premix in Tetra Pak, and a powder sachet including 
water purifier. The other options were statistically less appealing, though all 
were preferred to the current product. When respondents were asked for 
their purchase preference, the most popular was the premix in Tetra Pak. 
 
In Nigeria, the preferred options were the smaller powder sachet, the 
effervescent tablet, the premix in Tetra Pak, the premix in a pouch, and the 
co-pack with zinc. Respondents’ purchase preferences were the smaller 
sachet and premix in Tetra Pak. 
 
In Uganda, the preferred options were the smaller sachet, Tetra Pak, the 
sachet including water purifier, and the single packaging including zinc. The 
purchase preferences were the Tetra Pak and the single package including 
zinc. 
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Discussion 
Our theoretical analysis of the three case studies using the lens of SDL 
provides potential explanations for medicine appeal and acceptance based 
on cultural and environmental factors. We have found a common set of 
factors with specific country differences which could permit the extension 
of the findings to supply chains for other medicines and potentially for other 
products. 
 
It is clear that, as predicted from stakeholder interviews, there are multiple 
factors that lead a caregiver to decide whether a product is appealing. 
Firstly, even when caregivers are motivated to heal, they have differing 
levels of agency – that is, their capabilities vary. In India, for example, the 
respondents considered that the ORS/zinc co-pack was too complex for 
them (lack of personal competence), while in Uganda there was a strong 
need to demonstrate they were considering child safety (living up to 
perceptions of themselves or by others). Across the three countries, the 
most common agency issue was the lack of time that caregivers have 
available, which tended to direct them towards labour-saving premix 
formulations in the absence of price information. 
 
Secondly, value propositions of resources other than those of the ORS take 
on different levels of importance depending on the context in each country. 
In Nigeria, for example, the overriding issue with the co-pack was that water 
still had to be fetched in order to complete the resources required to co-
create value. 
 
Third and finally, we turn to the value proposition of ORS in the three 
contexts. The research showed that appeal depends on the affordances of 
both package appearance and formulation. Considering appearance, while 
the new packs were preferred over the old ones it was found that packs 
must be different in different contexts in order to have maximum appeal. 
Considering formulations, the products offering the highest affordances – 
lower cost, premixed, with additional ingredients, acceptable taste, in a co-
pack – held unsurprising appeal in general, but at a more detailed level the 
different combinations were considered to have different affordances in 
each country as a result of contextual variety. Caregivers were therefore 
seen to be comparing affordances of the offering against the availability to 
them of other value propositions (for example, clean water) and their own 
agency (time, money) in order to select their preferred compromises. 
 
SDL therefore provides a framework that facilitates an understanding of 
what is happening in both the pre-consumption (appeal and acceptance) 
and consumption (value co-creation) contexts. It becomes clear that, while 
changing the consumer’s agency can increase the likelihood of 
consumption, changing the product’s affordances (packaging, formulation) 
is at least as important. 
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This is where supply chains can make a difference. Once the target context 
is understood in sufficient detail, a product’s value proposition can be 
designed or refined so that its affordances achieve greatest appeal and 
acceptance in that context. Historically, supply chains have been reluctant 
to engage in the consumption space (Lusch, 2011). To facilitate this being 
considered part of supply chains’ remit, the concept of the “last yard” has 
been coined so that supply chain managers are more able to accommodate 
the idea that consumers should be “integrated into the supply chain” (ibid., 
p.16). One impact of this current research is that the supply chains 
responsible for the ORS and zinc products in the three focus markets are 
already taking action to add new formulations and to change packaging 
designs in response to the findings. 
 
Conclusions and further work 
The contribution of this research is significant. It confirms the hypotheses 
that both packaging and formulation can affect medicine’s appeal and 
acceptance, and therefore ultimately improve patient adherence. The 
results of the research provide practical guidance for supply chains on how 
to enhance the initiation and implementation phases of adherence by 
provoking purchase and encouraging persistence. 
 
Considering package design, while it is clear that improvements can increase 
the appeal of medicine, design details may have to be country-specific for 
optimum appeal and patient-centricity. In other words, it may not be 
possible to address all aspects of contextual variety with a single global 
design. Specific design details can only be finalised when supply chains 
understand the contexts of the target markets. 
 
We now move on to consider the formulations. The premix Tetra Pak option 
was consistently preferred. This addresses multiple concerns of caregivers in 
resource-poor contexts – the premix saves time, removes the need to fetch 
water, is robustly packaged, and is not unattractive to young children. 
However, associated supply chain costs may be higher than with sachets so 
this presents a challenge to supply chain partners. 
 
A smaller, lower-cost sachet with improved taste, which would lead to 
reduced wastage in use, was universally popular. Though a smaller sachet 
may increase the cost of packaging, it is one of the most cost-effective 
changes to bring to market. This research suggests that bringing a smaller 
sachet size into the private market (where the majority of caregivers in the 
focus countries seek treatment) will have a significant impact on adherence. 
There is a need for further research to understand the causes of the 
bitterness issue. However, combining these consistent findings on sachet 
size and taste indicates that a smaller-sized and better-tasting ORS product 
would be significantly more appealing and therefore be likely to improve 
adherence. 
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To date, results have been presented to local manufacturers and importers 
across the three focus countries. In Uttar Pradesh, India, the government is 
implementing pack design improvements for their ORS sachets at public 
health facilities (Figure 3(a)). Uganda currently has two local suppliers 
introducing the smaller sachet (Figure 3 (b)), two implementing pack design 
improvements and two suppliers launching a combined ORS/zinc pack. 
Nigeria now has five suppliers with co-packs on the market (Figure 3 (c)), 
two have implemented pack design improvements, and one will introduce 
smaller sachets in the longer term. 
 
 
 
 
Figure 3: (a) New Indian ORS sachet, (b) New Ugandan ORS sachet, (c) New 
Nigerian co-pack 
 
We believe that the approach taken in this research may also provide a new 
framework for assessing medicine appeal and acceptance more widely. In 
addition, it is likely that the same approach can be applied across other 
product groups such as pre-packaged food. 
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